Zynerba Pharmaceuticals OverviewZynerba Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ZYNE.
Quarterly Other Income/Expense
-$74576.00
↑ 89.1% YoY
As of Jun 30, 2023
Annual Other Income/Expense (TTM)
$769430.00
↑ 205.88% YoY
Trailing 12 months ending Jun 30, 2023